Skip to main content
SpringerLink
Log in

Breast Cancer in General Population

  • Chapter
The Outpatient Breast Clinic

  • 1115 Accesses

Abstract

• American Joint Committee on Cancer (AJCC) proposes the term multiple BCs rather than multifocal or multicentric BC. • The incidence of pregnancy-associated BC is the same as expected in general population, and also the ultimate comparison of prognosis, stage-for-stage and age-matched, may be similar. • Treatment of BC in young women is not substantially different from other age groups, and also systemic therapy is mainly linked to the biology of the tumor. However, in appropriate situations, it may also be important to evaluate very young women separately. • Management of BC in the elderly vulnerable and frail women could be a major challenge for oncologists and geriatricians alike. Dedicated oncologists are needed.

Future Directions. Many preconceptions about women are far from being cleared. Besides those related to individual variability, those related to age/biological age, fertility, and quality of life in complex contexts are equally important. There should be room for special situations such as a customized treatment for very young or elderly women.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Middleton LP, Vlastos G, Mirza NQ, Eva S, Sahin AA. Multicentric mammary carcinoma: evidence of monoclonal proliferation. Cancer. 2002;94:1910–6.

    Article  PubMed  Google Scholar 

  2. Coombs NJ, Boyages J. Multifocal and multicentric breast cancer: does each focus matter? J Clin Oncol. 2005;23:7497–502.

    Article  PubMed  Google Scholar 

  3. Holland R, Veling SH, Mravunac M, Hendriks JH. Histologic multifocality of Tis, T1-2 breast carcinomas. Implications for clinical trials of breast-conserving surgery. Cancer. 1985;56:979–90.

    Article  CAS  PubMed  Google Scholar 

  4. Tressera F, Rodriguez I, Garcia-Yuste M, Grases PJ, Ara C, Fabregas R. Tumor size and lymph node status in multifocal breast cancer. Breast J. 2007;13:68–71.

    Article  Google Scholar 

  5. Andea AA, Bouwman D, Wallis T, Visscher DW. Correlation of tumor volume and surface area with lymph node status in patients with multifocal/multicentric breast carcinoma. Cancer. 2006;200:20–7.

    Google Scholar 

  6. Katz A, Strom EA, Buchholz TA, Theriault R, Singletary SE, McNeese MD. The influence of pathologic tumor characteristics on locoregional recurrence rates following mastectomy. Int J Radiat Oncol Biol Phys. 2001;50:735–42.

    Article  CAS  PubMed  Google Scholar 

  7. Zonderland HM, Coerkamp EG, Hermans J, van de Vijver MJ, van Voorthuisen AE. Diagnosis of breast cancer: contribution of US as an adjunct to mammography. Radiology. 1999;213:413–22.

    Article  CAS  PubMed  Google Scholar 

  8. Houssami N, Ciatto S, Macaskill P, et al. Accuracy and surgical impact of magnetic resonance imaging in breast cancer staging: systematic review and meta-analysis in detection of multifocal and multicentric cancer. J Clin Oncol. 2008;26:3248–58.

    Article  PubMed  Google Scholar 

  9. Fowble B, Yeh IT, Schultz DJ, et al. The role of mastectomy in patients with stage I-II breast cancer presenting with gross multifocal or multicentric disease or diffuse microcalcifications. Int J Radiat Oncol Biol Phys. 1993;27:567–73.

    Article  CAS  PubMed  Google Scholar 

  10. Gentilini O, Botteri E, Rotmensz N, Da Lima L, Caliskan M, Garcia-Etienne CA, et al. Conservative surgery in patients with multifocal/multicentric breast cancer. Breast Cancer Res Treat. 2009;113:577–83.

    Article  PubMed  Google Scholar 

  11. Tot T. Clinical relevance of the distribution of the lesions in 500 consecutive breast cancer cases documented in large-format histologic sections. Cancer. 2007;110:2551–60.

    Article  PubMed  Google Scholar 

  12. Kim HJ, Lee JS, Park EH, et al. Sentinel node biopsy in patients with multiple breast cancer. Breast Cancer Res Treat. 2008;109:503–6.

    Article  CAS  PubMed  Google Scholar 

  13. Yerushalmi R, Kennecke H, Woods R, Olivotto IA, Speers C, Gelmon KA. Does multicentric/multifocal breast cancer differ from unifocal breast cancer? An analysis of survival and contralateral breast cancer incidence. Breast Cancer Res Treat. 2009;117:365–70.

    Article  CAS  PubMed  Google Scholar 

  14. Mavaddat N, Peock S, Frost D, et al. Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE. J Natl Cancer Inst. 2013;105:812–22.

    Article  CAS  PubMed  Google Scholar 

  15. Reiner AS, John EM, Brooks JD, et al. Risk of asynchronous contralateral breast cancer in noncarriers of BRCA1 and BRCA2 mutations with a family history of breast cancer: a report from the Women’s Environmental Cancer and Radiation Epidemiology Study. J Clin Oncol. 2013;31:433–9.

    Article  PubMed Central  PubMed  Google Scholar 

  16. Arpino G, Bardou VJ, Clark GM, Elledge RM. Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome. Breast Cancer Res. 2004;6:R149–56.

    Article  PubMed Central  PubMed  Google Scholar 

  17. Saltzman BS, Malone KE, McDougall JA, Daling JR, Li CI. Estrogen receptor, progesterone receptor, and HER2-neu expression in first primary breast cancers and risk of second primary contralateral breast cancer. Breast Cancer Res Treat. 2012;135:849–55.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  18. Barry M, Sacchini V. When is contralateral mastectomy warranted in unilateral breast cancer? Expert Rev Anticancer Ther. 2011;11:1209–14.

    Article  PubMed  Google Scholar 

  19. Vogel VG, Costantino JP, Wickerhan DL, et al. Update of the National Surgical Adjuvant Breast and Bowel Project Study of Tamoxifen and Raloxifene (STAR) P-2 trial: preventing breast cancer. Cancer Prev Res. 2010;3:696–706.

    Article  CAS  Google Scholar 

  20. Hartman M, Czene K, Reilly M, et al. Incidence and prognosis of synchronous and metachronous bilateral breast cancer. J Clin Oncol. 2007;25:4210–6.

    Article  PubMed  Google Scholar 

  21. Psyrri A, Burtness B. Pregnancy-associated breast cancer. Cancer J. 2005;11:83–95.

    Article  PubMed  Google Scholar 

  22. Anders CK, Johnson R, Litton J, Phillips M, Bleyer A. Breast cancer before age 40 years. Semin Oncol. 2009;36:237–49.

    Article  PubMed Central  PubMed  Google Scholar 

  23. Anderson BO, Petrek JA, Byrd DR, Senie RT, Borgen PI. Pregnancy influences breast cancer stage at diagnosis in women 30 years of age and younger. Ann Surg Oncol. 1996;3:204–11.

    Article  CAS  PubMed  Google Scholar 

  24. Wohlfahrt J, Olsen JH, Melby M. Breast cancer risk after childbirth in young women with family history (Denmark). Cancer Causes Control. 2002;13:169–74.

    Article  PubMed  Google Scholar 

  25. Ulery M, Carter L, McFarlin BL, Giurgescu C. Pregnancy-associated breast cancer: significance of early detection. J Midwifery Womens Health. 2009;54:357–63.

    Article  PubMed  Google Scholar 

  26. Oto A, Ernst R, Jesse MK, Chaljub G, Saade G. Magnetic resonance imaging of the chest, abdomen, and pelvis in the evaluation of pregnant patients with neoplasms. Am J Perinatol. 2007;24:243–50.

    Article  PubMed  Google Scholar 

  27. Kanal E, Barkovich AJ, Bell C, et al. ACR guidance document for safe MR practices. AJR Am J Roentgenol. 2007;188:1447–74.

    Article  PubMed  Google Scholar 

  28. Shannon J, Douglas-Jones AG, Dallimore NS. Conversion to core biopsy in preoperative diagnosis of breast lesions: is it justified by results? J Clin Pathol. 2001;54:762–5.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  29. Loibl S, von Minckwitz G, Gwyn K, et al. Breast carcinoma during pregnancy. International recommendations from an expert meeting. Cancer. 2006;106:237–46.

    Article  PubMed  Google Scholar 

  30. Halaska MJ, Pentheroudakis G, Strnad P, et al. Presentation, management and outcome of 32 patients with pregnancy-associated breast cancer: a matched controlled study. Breast J. 2009;15:461–7.

    Article  PubMed  Google Scholar 

  31. Moran BJ, Yano H, Al Zahir N, Farquharson M. Conflicting priorities in surgical intervention for cancer in pregnancy. Lancet Oncol. 2007;8:536–44.

    Article  PubMed  Google Scholar 

  32. Toesca A, Gentilini O, Peccatori F, Azim H, Amant F. Locoregional treatment of breast cancer during pregnancy. Gynecol Surg. 2014;11:279–84.

    Article  PubMed Central  PubMed  Google Scholar 

  33. Gentilini O, Cremonesi M, Toesca A, et al. Sentinel lymph node biopsy in pregnant patients with breast cancer. Eur J Nucl Med Mol Imaging. 2010;37:78–83.

    Article  PubMed  Google Scholar 

  34. Peccatori FA, Azim Jr HA, Scarfone G, et al. Weekly epirubicin in the treatment of gestational breast cancer (GBC). Breast Cancer Res Treat. 2009;115:591–4.

    Article  CAS  PubMed  Google Scholar 

  35. Isaacs RJ, Hunter W, Clark K. Tamoxifen as systemic treatment of advanced breast cancer during pregnancy—case report and literature review. Gynecol Oncol. 2001;80:405–8.

    Article  CAS  PubMed  Google Scholar 

  36. Azim Jr HA, Santoro L, Pavlidis N, et al. Safety of pregnancy following breast cancer diagnosis: a meta-analysis of 14 studies. Eur J Cancer. 2011;47:74–83.

    Article  PubMed  Google Scholar 

  37. Cardoso F, Loibl S, Pagani O, et al. The European Society of Breast Cancer Specialists recommendations for the management of young women with breast cancer. Eur J Cancer. 2012;48:3355–77.

    Article  PubMed  Google Scholar 

  38. Amant F, Deckers S, Van Calsteren K, et al. Breast cancer in pregnancy: recommendations of an international consensus meeting. Eur J Cancer. 2010;46(18):3158–68.

    Article  PubMed  Google Scholar 

  39. Azim Jr HA, Bellettini G, Liptrott SJ, et al. Breastfeeding in breast cancer survivors: pattern, behaviour and effect on breast cancer outcome. Breast. 2010;19:527–31.

    Article  PubMed  Google Scholar 

  40. Gabriel CA, Domchek SM. Breast cancer in young women. Breast Cancer Res. 2010;12:212.

    Article  PubMed Central  PubMed  Google Scholar 

  41. Assi HA, Khoury KE, Dbouk H, Khalil LE, Mouhieddine TH, El Saghir NS. Epidemiology and prognosis of breast cancer in young women. J Thorac Dis. 2013;5:S2–8.

    PubMed Central  PubMed  Google Scholar 

  42. de Bock GH, van der Hage JA, Putter H, Bonnema J, Bartelink H, van de Velde CJ. Isolated loco-regional recurrence of breast cancer is more common in young patients and following breast conserving therapy: long-term results of European Organisation for Research and Treatment of Cancer studies. Eur J Cancer. 2006;42:351–6.

    Article  PubMed  Google Scholar 

  43. Wapnir IL, Anderson SJ, Mamounas EP, et al. Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in five National Surgical Adjuvant Breast and Bowel Project node-positive adjuvant breast cancer trials. J Clin Oncol. 2006;24:2028–37.

    Article  PubMed  Google Scholar 

  44. Hartman M, Czene K, Reilly M, et al. Genetic implications of bilateral breast cancer: a population based cohort study. Lancet Oncol. 2005;6:377–82.

    Article  PubMed  Google Scholar 

  45. Gnerlich JL, Deshpande AD, Jeffe DB, Sweet A, White N, Margenthaler JA. Elevated breast cancer mortality in women younger than age 40 years compared with older women is attributed to poorer survival in early-stage disease. J Am Coll Surg. 2009;208:341–7.

    Article  PubMed Central  PubMed  Google Scholar 

  46. Morrow M, Waters J, Morris E. MRI for breast cancer screening, diagnosis, and treatment. Lancet. 2011;378(9805):1804–11.

    Article  PubMed  Google Scholar 

  47. Golshan M, Miron A, Nixon AJ, et al. The prevalence of germline BRCA1 and BRCA2 mutations in young women with breast cancer undergoing breast-conservation therapy. Am J Surg. 2006;192:58–62.

    Article  CAS  PubMed  Google Scholar 

  48. Mester JL, Moore RA, Eng C. PTEN germline mutations in patients initially tested for other hereditary cancer syndromes: would use of risk assessment tools reduce genetic testing? Oncologist. 2013;18:1083–90.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  49. Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002;347:1233–41.

    Article  PubMed  Google Scholar 

  50. Poortmans PM, Collette L, Bartelink H, et al. The addition of a boost dose on the primary tumour bed after lumpectomy in breast conserving treatment for breast cancer. A summary of the results of EORTC 22881–10882 “boost versus no boost” trial. Cancer Radiother. 2008;12:565–70.

    Article  CAS  PubMed  Google Scholar 

  51. Shah C, Khan AJ, Arthur D, Fernandez E, Martinez AA, Vicini F. Intraoperative radiation therapy in breast cancer: not ready for prime time. Ann Surg Oncol. 2014;21:351–3.

    Article  PubMed  Google Scholar 

  52. Davies C, Godwin J, Gray R, et al. Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials. Lancet. 2011;378(9793):771–84.

    Article  CAS  PubMed  Google Scholar 

  53. Davies C, Pan H, Godwin J, et al. Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial. Lancet. 2013;381:805–16.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  54. Partridge AH, Gelber S, Piccart-Gebhart MJ, et al. Effect of age on breast cancer outcomes in women with human epidermal growth factor receptor 2-positive breast cancer: results from a herceptin adjuvant trial. J Clin Oncol. 2013;31:2692–8.

    Article  CAS  PubMed  Google Scholar 

  55. Michaud LB, Jones KL, Buzdar AU. Combination endocrine therapy in the management of breast cancer. Oncologist. 2001;6:538–46.

    Article  CAS  PubMed  Google Scholar 

  56. Bernstein JL, Thomas DC, Shore RE, et al. Contralateral breast cancer after radiotherapy among BRCA1 and BRCA2 mutation carriers: a WECARE study report. Eur J Cancer. 2013;49(14):2979–85.

    Article  PubMed Central  PubMed  Google Scholar 

  57. Domchek SM, Friebel TM, Singer CF, et al. Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality. JAMA. 2010;304:967–75.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  58. Loren AW, Mangu PB, Beck LN, et al. Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol. 2013;31:2500–10.

    Article  PubMed  Google Scholar 

  59. Blanc B, Lazard A, Estrade JP, Agostini A, Gurriet B. Contraceptive methods after gynecological and breast cancer. Bull Acad Natl Med. 2010;194:521–7.

    PubMed  Google Scholar 

  60. Lee MC, Bhati RS, von Rottenthaler EE, et al. Therapy choices and quality of life in young breast cancer survivors: a short-term follow-up. Am J Surg. 2013;206:625–31.

    Article  PubMed  Google Scholar 

  61. Broeckel JA, Thors CL, Jacobsen PB, Small M, Cox CE. Sexual functioning in long-term breast cancer survivors treated with adjuvant chemotherapy. Breast Cancer Res Treat. 2002;75:241–8.

    Article  PubMed  Google Scholar 

  62. Bouchardy C, Rapiti E, Fioretta G, et al. Undertreatment strongly decreases prognosis of breast cancer in elderly women. J Clin Oncol. 2003;21:3580–7.

    Article  PubMed  Google Scholar 

  63. Schonberg MA, Marcantonio ER, Li D, Silliman RA, Ngo L, McCarthy EP. Breast cancer among the oldest old: tumor characteristics, treatment choices, and survival. J Clin Oncol. 2010;28:2038–45.

    Article  PubMed Central  PubMed  Google Scholar 

  64. Rosso S, Gondos A, Zanetti R, et al. Up-to-date estimates of breast cancer survival for the years 2000–2004 in 11 European countries: the role of screening and a comparison with data from the United States. Eur J Cancer. 2010;46:3351–7.

    Article  PubMed  Google Scholar 

  65. Satariano WA, Ragland DR. The effect of comorbidity on 3-year survival of women with primary breast cancer. Ann Intern Med. 1994;120:104–10.

    Article  CAS  PubMed  Google Scholar 

  66. Stotter A, Tahir M, Pretorius R, Robinson T. Experiences of a multidisciplinary elderly breast cancer clinic: using the right specialists, in the same place, with time. In: Reed M, Audisio R, editors. Management of breast cancer in older women. London: Springer; 2010.

    Google Scholar 

  67. Pallis AG, Fortpied C, Wedding U, et al. EORTC elderly task force position paper: approach to the older cancer patient. Eur J Cancer. 2010;46:1502–13.

    Article  CAS  PubMed  Google Scholar 

  68. Martelli G, Boracchi P, De Palo M, et al. A randomized trial comparing axillary dissection to no axillary dissection in older patients with T1N0 breast cancer: results after 5 years of follow-up. Ann Surg. 2005;242:1–6.

    Article  PubMed Central  PubMed  Google Scholar 

  69. Rudenstam CM, Zahrieh D, Forbes JF, et al. Randomized trial comparing axillary clearance versus no axillary clearance in older patients with breast cancer: first results of International Breast Cancer Study Group Trial 10–93. J Clin Oncol. 2006;24:337–44.

    Article  PubMed  Google Scholar 

  70. Hughes KS, Schnaper LA, Berry D, et al. Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer. N Engl J Med. 2004;351:971–7.

    Article  CAS  PubMed  Google Scholar 

  71. Vaidya JS, Joseph DJ, Tobias JS, et al. Targeted intraoperative radiotherapy versus whole breast radiotherapy for breast cancer (TARGIT-A trial): an international, prospective, randomised, non-inferiority phase 3 trial. Lancet. 2010;376:91–102.

    Article  PubMed  Google Scholar 

  72. Hind D, Wyld L, Reed MW. Surgery, with or without tamoxifen, vs tamoxifen alone for older women with operable breast cancer: Cochrane review. Br J Cancer. 2007;96:1025–9.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  73. Biganzoli L, Licitra S, Claudino W, et al. Clinical decision making in breast cancer: TAM and aromatase inhibitors for older patients—a jungle? Eur J Cancer. 2007;43:2270–8.

    Article  CAS  PubMed  Google Scholar 

  74. Garg P, Rana F, Gupta R, Buzaianu EM, Guthrie TH. Predictors of toxicity and toxicity profile of adjuvant chemotherapy in elderly breast cancer patients. Breast J. 2009;15:40.

    Article  Google Scholar 

  75. Loibl S, von Minckwitz G, Harbeck N, et al. Clinical feasibility of (neo)adjuvant taxane-based chemotherapy in older patients: analysis of >4,500 patients from four German randomized breast cancer trials. Breast Cancer Res. 2008;10:R77.

    Article  PubMed Central  PubMed  Google Scholar 

Further Reading

  • Azim Jr HA, Del Mastro L, Scarfone G, et al. Treatment of breast cancer during pregnancy: regimen selection, pregnancy, monitoring and more. Breast. 2011;20:1–6.

    Article  PubMed  Google Scholar 

  • Biganzoli L, Wildiers H, Oakman C, et al. Management of elderly patients with breast cancer: updated recommendations of the International Society of Geriatric Oncology (SIOG) and European Society of Breast Cancer Specialists (EUSOMA). Lancet Oncol. 2012;13:148–60.

    Article  Google Scholar 

  • Cardonick E, Dougherty R, Grana G, et al. Breast cancer during pregnancy: maternal and fetal outcomes. Cancer J. 2010;16:76–82.

    Article  PubMed  Google Scholar 

  • Cardoso F, Loibl S, Pagani O, et al. The European Society of Breast Cancer Specialists recommendations for the management of young women with breast cancer. Eur J Cancer. 2012;48:3355–77.

    Article  PubMed  Google Scholar 

  • Garcia-Manero M, Royo MP, Espinos J, et al. Pregnancy associated breast cancer. Eur J Surg Oncol. 2009;35:215–8.

    Article  CAS  PubMed  Google Scholar 

  • Kell MR, Morrow M. Multifocal, multicentric and bilateral breast cancer. In: Hudis CA, Norton L, Winchester DJ, Winchester DP, editors. Breast cancer. Hamilton: BC Decker; 2006.

    Google Scholar 

  • Le Saux O, Ripamonti B, Bruyas A, et al. Optimal management of breast cancer in the elderly patient: current perspectives. Clin Interv Aging. 2015;6(10):157–74.

    Google Scholar 

  • Li Z, Sergent F, Bolla M, Zhou Y, Gabelle-Flandin I. Prognostic factors of second primary contralateral breast cancer in early-stage breast cancer. Oncol Lett. 2015;9:245–51.

    PubMed Central  PubMed  Google Scholar 

  • Méry B, Avi Assouline A, Rivoirard R, et al. Portrait, treatment choices and management of breast cancer in nonagenarians: an ongoing challenge. Breast. 2014;23:221–5.

    Article  PubMed  Google Scholar 

  • Mustacchi G, Scanni A, Capasso I, Farris A, Pluchinotta A, Isola G. Update of the Phase III trial ‘GRETA’ of surgery and tamoxifen versus tamoxifen alone for early breast cancer in elderly women. Future Oncol. 2014;10:1–9.

    Google Scholar 

  • Ogunbiyi SO, Lee S, Mathew J, Cheung KL. Primary breast cancer in the elderly: a systematic literature review on histological type and clinical outcome. Future Oncol. 2015;11:259–65.

    Article  CAS  PubMed  Google Scholar 

  • Partridge AH, Pagani O, Abulkhair O, et al. First international consensus guidelines for breast cancer in young women (BCY1). Breast. 2014;23:209–20.

    Article  PubMed  Google Scholar 

  • Senkus E. Synchronous and metachronous metastatic breast cancer – two incarnations of the same beast? Breast. 2014;23:1.

    Article  PubMed  Google Scholar 

  • Shaikh T, Tam TY, Li T, et al. Multifocal and multicentric breast cancer is associated with increased local recurrence regardless of surgery type. Breast J. 2015. doi:10.1186/1471-2407-13-361.

    PubMed  Google Scholar 

  • Tomasi-Cont N, Lambertini M, Hulsbosch S, Peccatori AF, Amant F. Strategies for fertility preservation in young early breast cancer patients. Breast. 2014;23:503–10.

    Article  PubMed  Google Scholar 

  • Websites in Appendix: Fertility, A-4.9; Young Women, A-4.23.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Breast Surgery, European Institute of Oncology (IEO), Milano, Italy

    Oreste D. Gentilini & Maria Virginia Thomazini

Authors
  1. Oreste D. Gentilini
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Maria Virginia Thomazini
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Oreste D. Gentilini .

Editor information

Editors and Affiliations

  1. Breast Surgery Department Consultant Surgeon, Polyclinic Abano Terme, Padova, Italy

    Alfonso M. Pluchinotta

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Gentilini, O.D., Thomazini, M.V. (2015). Breast Cancer in General Population. In: Pluchinotta, A. (eds) The Outpatient Breast Clinic. Springer, Cham. https://doi.org/10.1007/978-3-319-15907-2_15

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-15907-2_15

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-15906-5

  • Online ISBN: 978-3-319-15907-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation